News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
404,942 Results
Type
Article (17167)
Company Profile (291)
Press Release (387484)
Multimedia
Podcasts (48)
Webinars (9)
Section
Business (127798)
Career Advice (570)
Deals (22776)
Drug Delivery (39)
Drug Development (57399)
Employer Resources (54)
FDA (8015)
Job Trends (7636)
News (213431)
Policy (15046)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1103)
Accelerated approval (4)
Adcomms (14)
Allergies (56)
Alliances (30358)
ALS (65)
Alzheimer's disease (934)
Antibody-drug conjugate (ADC) (92)
Approvals (8043)
Artificial intelligence (129)
Autoimmune disease (17)
Automation (6)
Bankruptcy (174)
Best Places to Work (6262)
BIOSECURE Act (5)
Biosimilars (49)
Biotechnology (245)
Bladder cancer (47)
Brain cancer (21)
Breast cancer (170)
Cancer (1502)
Cardiovascular disease (124)
Career advice (485)
Career pathing (4)
CAR-T (112)
Cell therapy (333)
Cervical cancer (8)
Clinical research (46832)
Collaboration (587)
Compensation (356)
Complete response letters (14)
COVID-19 (1189)
CRISPR (39)
C-suite (189)
Cystic fibrosis (79)
Data (1554)
Denatured (11)
Depression (31)
Diabetes (143)
Diagnostics (3003)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (17)
Drug discovery (87)
Drug pricing (32)
Drug shortages (4)
Duchenne muscular dystrophy (89)
Earnings (53848)
Editorial (19)
Employer branding (9)
Employer resources (53)
Events (70734)
Executive appointments (556)
FDA (8786)
Featured Employer (34)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (554)
Gene editing (94)
Generative AI (10)
Gene therapy (254)
GLP-1 (416)
Government (1346)
Grass and pollen (2)
Guidances (25)
Healthcare (9652)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (92)
Indications (19)
Infectious disease (1260)
Inflammatory bowel disease (112)
Inflation Reduction Act (8)
Influenza (22)
Intellectual property (70)
Interviews (67)
IPO (11714)
IRA (11)
Job creations (1679)
Job search strategy (450)
Kidney cancer (7)
Labor market (8)
Layoffs (257)
Leadership (6)
Legal (3307)
Liver cancer (39)
Lung cancer (203)
Lymphoma (96)
Machine learning (2)
Management (16)
Manufacturing (150)
MASH (57)
Medical device (5743)
Medtech (5745)
Mergers & acquisitions (11481)
Metabolic disorders (421)
Multiple sclerosis (55)
NASH (15)
Neurodegenerative disease (65)
Neuropsychiatric disorders (23)
Neuroscience (1341)
NextGen: Class of 2025 (3198)
Non-profit (1461)
Northern California (1929)
Now hiring (23)
Obesity (216)
Opinion (125)
Ovarian cancer (63)
Pain (47)
Pancreatic cancer (59)
Parkinson's disease (123)
Partnered (11)
Patents (129)
Patient recruitment (72)
Peanut (38)
People (38904)
Pharmaceutical (49)
Pharmacy benefit managers (6)
Phase I (15931)
Phase II (21334)
Phase III (14378)
Pipeline (927)
Policy (47)
Postmarket research (1241)
Preclinical (6648)
Press Release (67)
Prostate cancer (70)
Psychedelics (35)
Radiopharmaceuticals (234)
Rare diseases (300)
Real estate (2831)
Recruiting (19)
Regulatory (11596)
Reports (20)
Research institute (1119)
Resumes & cover letters (79)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (60)
Series A (102)
Series B (68)
Service/supplier (1)
Sickle cell disease (41)
Southern California (1655)
Special edition (11)
Spinal muscular atrophy (120)
Sponsored (14)
Startups (2447)
State (1)
Stomach cancer (5)
Supply chain (26)
Tariffs (8)
The Weekly (36)
United States (15554)
Vaccines (229)
Venture capitalists (30)
Weight loss (121)
Women's health (15)
Worklife (2)
Date
Today (12)
Last 7 days (311)
Last 30 days (1572)
Last 365 days (23642)
2025 (6714)
2024 (25209)
2023 (28228)
2022 (36107)
2021 (37900)
2020 (33547)
2019 (24353)
2018 (18371)
2017 (19465)
2016 (17434)
2015 (21621)
2014 (16664)
2013 (12944)
2012 (13645)
2011 (14150)
2010 (13900)
Location
Africa (297)
Alabama (43)
Alaska (3)
Arizona (100)
Arkansas (5)
Asia (23725)
Australia (3710)
California (4361)
Canada (1414)
China (353)
Colorado (165)
Connecticut (181)
Delaware (102)
Europe (50725)
Florida (554)
Georgia (127)
Idaho (26)
Illinois (292)
India (13)
Indiana (122)
Iowa (2)
Japan (109)
Kansas (73)
Kentucky (13)
Louisiana (7)
Maine (49)
Maryland (516)
Massachusetts (3488)
Michigan (142)
Minnesota (223)
Mississippi (2)
Missouri (42)
Montana (18)
Nebraska (16)
Nevada (28)
New Hampshire (29)
New Jersey (1164)
New Mexico (14)
New York (1162)
North Carolina (674)
North Dakota (5)
Northern California (1929)
Ohio (134)
Oklahoma (10)
Oregon (22)
Pennsylvania (842)
Puerto Rico (5)
Rhode Island (23)
South America (433)
South Carolina (7)
Southern California (1655)
Tennessee (57)
Texas (541)
Utah (97)
Virginia (100)
Washington D.C. (36)
Washington State (391)
West Virginia (2)
Wisconsin (28)
404,942 Results for "invivo therapeutics corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Turn Therapeutics Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-Vivo
In a widely cited in-vivo model of atopic dermatitis, Turn Therapeutics’ atopic dermatitis candidate showed a dramatic reduction in disease severity versus placebo.
June 20, 2024
·
2 min read
Press Releases
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
December 10, 2024
·
3 min read
Small Animal Imaging (In-Vivo) Market Expecting a Surge in Revenue of US$ 1,902 Million By 2032
The global small animal imaging (In-Vivo) market was valued at US$ 1,053 million in 2023.
May 2, 2024
·
7 min read
Deals
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
Bruker Corporation announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems.
February 6, 2024
·
3 min read
Press Releases
CARGO Therapeutics Provides Corporate Update
March 18, 2025
·
4 min read
Genetown
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced topline results from the company’s INSPIRE 2.0 study, which was designed to evaluate the safety and probable benefit of InVivo’s investigational Neuro-Spinal Scaffold™, a bioresorbable scaffold-based device in development for patients with acute SCI.
March 9, 2023
·
3 min read
Press Releases
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update
April 10, 2025
·
2 min read
Press Releases
Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results
April 1, 2025
·
11 min read
Press Releases
Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates
April 1, 2025
·
11 min read
Press Releases
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
September 25, 2024
·
7 min read
1 of 40,495
Next
